{
    "url_original": "https://www.wsj.com/articles/biogens-new-alzheimers-drug-meets-slow-rollout-11634733079?mod=business_lead_pos1",
    "url": "biogens-new-alzheimers-drug-meets-slow-rollout-11634733079",
    "title": "Biogen’s New Alzheimer’s Drug Meets Slow Rollout",
    "sub_head": "Revenue from the drug, Aduhelm, was $300,000 in the first full quarter of sales",
    "category_1": "Business",
    "image_1_url": "https://images.wsj.net/im-419791?width=860&height=573",
    "image_1": "im-419791.jpg",
    "time": "2021-10-20 08:31:00"
}